Swissmedic Newsletter and Updates

Newsletter

New on the website

06.03.2023
Fachassistent/in (50%)
Job advertisement | Abteilung Klinische Versuche (KLV)

06.03.2023
Swissmedic Journal
Latest edition
Swissmedic Journal Februar 2023

03.03.2023
Authorisations of complementary and herbal medicinal products in 2022
This report provides, among other things,  an overview of the number of authorisations of complementary and herbal  medicines with indication and complementary medicines without indication  in 2022.

02.03.2023
Authorisations of human medicinal products with a new active substance and additional indications 2022
47 human medicinal products with new active substances authorised

01.03.2023
Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update
Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

01.03.2023
Changes to the guidance document Product information for human medicinal products
The detailed Information for healthcare professionals and Patient information templates are being withdrawn

01.03.2023
DHPC  – Januskinase (JAK)-Inhibitoren / Cibinqo® (Abrocitinib), Olumiant®  (Baricitinib), Rinvoq® (Upadacitinib) und Xeljanz® (Tofacitinib)
Erhöhtes Risiko für Malignome,  schwerwiegende kardiovaskuläre Ereignisse (MACE), schwerwiegende  Infektionen, Thrombosen und Gesamtmortalität

01.03.2023
New Mobile technologies guidance document for human and veterinary medicinal products
Regulations on the use of QR codes on packaging and in medicinal product information

View all updates...